Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-30.72%
↓ 172% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-11.30%
Historical baseline
PeriodValue
2025-30.72%
202423.24%
2023-17.66%
2022-42.67%
20210.00%
20200.00%